Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy

Chest

Volumn 113, Issue 3, 1998, Pages 696-702

  Lam, Stephen ^a,j   Kennedy, Timothy ^b   Unger, Michael ^c   Miller, York E ^b   Gelmont, David ^d   Rusch, Valerie ^e   Gipe, Bruce ^f   Howard, David ^g   LeRiche, Jean C ^h   Coldman, Andrew ^h   Gazdar, Adi F ⁱ  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c PENNSYLVANIA HOSPITAL   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Evansville Surgical Associates   (United States)

^h BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

ⁱ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^j NONE   (Canada)

more..

Author keywords

Autofluorescence; Bronchoscopy; Early detection; Lung neoplasm

Indexed keywords

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; BRONCHOSCOPY; CANCER LOCALIZATION; CANCER STAGING; CARCINOMA IN SITU; CLINICAL TRIAL; DEVICE; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ENDOSCOPE; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; LUNG CARCINOMA; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL;

EID: 6844252883     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.3.696     Document Type: Article

References (40)

1. Fry WA, Menck HR, Winchester DP. The national cancer data base report on lung cancer. Cancer 1996; 77:1947-55
2. Anderson GH, Boyes DA, Benedet JL, et al. Organization and results of the cervical cytology screening program in British Columbia, 1955-85. BMJ 1988; 296:975-78
3. Winawer SJ, Zauber AC, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81
4. Jiang T, Van S, Zhao L. Preventing effect of 'liuwei dihuang decoction' on esophageal carcinoma. Jpn J Cancer Chemother 1989; 16:1511-18
5. Ozenne G, Vergnon JM, Roullier A, et al. Cryotherapy of in situ or microinvasive bronchial carcinoma [abstract]. Chest 1990; 98:105S
6. Cavaliere S, Foccoli P, Toninelli C, et al. Nd:YAG laser therapy in lung cancer: an 11-year experience with 2,253 applications in 1,585 patients. J Bronchol 1994; 1:105-11
7. Sutedja TG, Schreurs AJ, Vanderschueren RG, et al. Bronchoscopic therapy in patients with intraluminal typical bronchial carcinoid. Chest 1995; 107:556-58
8. Furuse K, Fukuoka M, Kato H, et al. A prospective phase II study of photodynamic therapy with Photofrin II for centrally located early-stage lung cancer. J Clin Oncol 1993; 11: 1852-57
9. Woolner LB. Pathology of cancer detected cytologically. In: Atlas of early lung cancer: National Cancer Institute, National Institute of Health, US Department of Health and Human Services. Tokyo: Igaku-Shoin, 1983; 107-213
10. Palcic B, Lam S, Hung J, et al. Detection and localization of early lung cancer by imaging techniques. Chest 1991; 99: 742-43
11. Hung J, Lam S, LeRiche JC, et al. Antofluorescence of normal and malignant bronchial tissue. Lasers Surg Med 1991: 11:99-105
12. Lam S, MacAulay C, Hung J, et al. Detection of dysplasia and carcinoma in situ using a lung imaging fluorescence endoscopy (LIFE) device. J Thorac Cardiovasc Surg 1993; 105: 1035-40
13. Lam S. MacAulay C, LeRiche JC, et al. Early localization of bronchogenic carcinoma. Diagn Ther Eudosc 1994; 1:75-78
14. Risse EXJ, Vooijs GP, van't Hof MA. Diagnostic significance of 'severe dysplasia' in sputum cytology. Acta Cytol 1988; 32:629-34
15. Band P, Feldstein M, Saccomanno G. Reversibility of bronchial marked atypia: implication for chemoprevention. Cancer Detect Treat 1986; 9:157-60
16. Frost JK, Ball WC Jr, Levin MI, et al. Sputum cytology: use and potential in monitoring the workplace environment by screening for biological effects of exposure. J Occup Med 1986; 28:692-703
17. Lam S, Profio AE. Fluorescence tumor detection. In: Hetzel MR. ed. Minimally invasive techniques in thoracic medicine and surgery. London: Chapman & Hall, 1995; 179-91
18. Boone CW, Kelloff GJ. Intraepithelial neoplasia, surrogate endpoint biomarkers and cancer chemoprevention. J Cell Biochem Suppl 1993: 17F:37-48
19. Yogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993; 9:138-41
20. Woolner LB, Fontana RS, Cortese DA, et al. Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc 1984; 59:453-66
21. Cortese DA, Pairolero PC, Bergsralh EJ, et al. Roentgenographically occult lung cancer: a 10 year experience. J Thorac Cardiovasc Surg 1983; 86:373-80
22. Bechtel JJ, Kelly WR, Petty TL, et al. Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytologic testing: a community hospital program. Arch Intern Med 1994; 154:975-80
23. Holiday DB, McLarty JW, Farley ML, et al. Sputum cytology within and across laboratories: a reliability study. Acta Cytol 1995; 39:195-206
24. Archer PC, Koprowska I, McDonald JH, et al. A study of variability in the interpretation of sputum cytology slides. Cancer Res 1966; 26:2122-44
25. Lam S, MacAulay C, Palcic B. Detection and localization of early lung cancer by imaging techniques, Chest 1993; 103: 12S-14S
26. Garner D, Ferguson G, Palcic B. The Cyto-Savant System. In: Grohs HK, Husain OAN, eds. Automated cervical cancer screening. Hong Kong: Igaku-Shoin Medical Publishers, 1994; 305-17
27. Thiberville L, Payne P, Vielkinds J, et al. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res 1995; 55:5133-39
28. Hung J, Kashimoto Y, Sugio K, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 1995; 273:558-63
29. Sundaresan V, Ganly P, Haselton P, et al. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumors, are detectable in preinvasive lesions of the bronchus. Oncogene 1992; 7:1989-97
30. Bolon I, Brambilla E, Vandenbunder B, et al. Changes in the expression of matris proteases and of the transcription factor c-Ets1 during progression of precancerous bronchial lesions. Lab Invest 1996; 75:1-13
31. Qu J, MacAulay C, Lam S, et al. Optical properties of normal and carcinoma bronchial tissue. Appl Optics 1991; 11:99-105
32. Qu J, MacAulay C, Lam S, et al. Laser induced fluorescence spectroscopy at endoscopy: tissue optics: Monte Cario modeling and in vivo measurements. Optical Eng 1995; 34: 3334-43
33. Kennedy TC, Proudfoot S, Franklin WA, et al. Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories. Cancer Res 1996; 56: 4673-78
34. Tockman MS, Gupta PK, Meyers JD, et al. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells; a new approach to early lung cancer detection. J Clin Oncol 1988; 6:1685-93
35. Tockman MS, Erozan YS, Gupta P, et al. The early detection of second primary lung cancers by sputum immunostaining. Chest 1994; 106:385S-90S
36. Mao L, Hruban RH, Boyle JO, et al. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Bes 1994; 54:1634-37
37. Early lung cancer detection: summary and conclusions. Am Rev Respir Dis 1984: 130:565-70
38. Kato H, Okunaka T, Shimatani H. Photodynamic therapy for early stage bronchogenic carcinoma. J Clin Laser Med Surg 1996; 14:235-38
39. Cortese DA. Bronchoscopic photodynamic therapy of radiologically occult lung cancer: the American experience. In: Hetzel MR, ed. Minimally invasive techniques in thoracic medicine and surgery. London: Chapman & Hall, 1995; 173-78
40. Greenvald P, Kelloff G, Burch-Whitman C, et al. Chemoprevention. CA Cancer J Clin 1995; 45:31-49